1 / 22

Introduction to Clinical Pharmacology Chapter 18- Central Nervous System Stimulants

Introduction to Clinical Pharmacology Chapter 18- Central Nervous System Stimulants. CNS Stimulants: Action. Analeptics: Increase depth of respirations Caffeine:

mateja
Download Presentation

Introduction to Clinical Pharmacology Chapter 18- Central Nervous System Stimulants

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Introduction to Clinical PharmacologyChapter 18-Central Nervous System Stimulants

  2. CNS Stimulants: Action • Analeptics: • Increase depth of respirations • Caffeine: • Cardiac stimulation; dilation of coronary; peripheral blood vessels; constriction of cerebral blood vessels; skeletal muscle stimulation

  3. CNS stimulants: Actions (cont’d) • Modafinil: • Exact mechanism of action is not known, but drug is thought to bind to dopamine thereby reducing number of episodes • Amphetamines (sympathomimetics): • Elevate blood pressure; wakefulness; increase or decrease-pulse rate; produce euphoric state • Anorexiants: Suppress appetite

  4. CNS Stimulants: Uses • CNS stimulants-treatment: • *Attention deficit hyperactivity disorder • *drug-induced respiratory depression • postanesthesia respiratory depression without reduction of analgesia • narcolepsy • *sleep apnea • exogenous obesity • fatigue

  5. CNS Stimulants: Adverse Reactions • Neuromuscular reactions: • Excessive CNS stimulation; headache; dizziness; apprehension; disorientation; hyperactivity • Other: • Nausea; vomiting; cough; dyspnea; urinary retention; tachycardia; palpitations; anorexia

  6. CNS Stimulants: Contraindications • CNS stimulants contraindicated: • Inpatients with known hypersensitivity; convulsive disorders; ventilation mechanism disorders • Nurse should not administer CNS stimulants to patients with: • Cardiac problems; severe hypertension; hyperthyroidism • Amphetamines: • *Contraindicated in glaucoma • *Amphetamines and anorexiants should not be taken concurrently or within 14 days of antidepressant medications

  7. CNS Stimulant: Interactions

  8. Nursing Process: Assessment • Preadministration assessment: • Respiratory depression: • Initial assessments: Blood pressure, pulse, respiratory rate • Note: Depth of respirations; any pattern to respiratory rate • Review: Recent laboratory test results

  9. Nursing Process: Assessment • Preadministration assessment (cont’d): • Attention deficit hyperactivity disorder: • Amphetamine prescribed: Weigh patient and take blood pressure; pulse; and respiratory rate • Child with ADHD: Observe for patterns of abnormal behavior • Record summary: Document/chart client’s behavior; provides comparison/future changes

  10. Nursing Process: Assessment • Preadministration assessment (cont’d): • Obesity: • Anorexiant or amphetamine: • Used for outpatient use • Obtain and record: • Blood pressure; pulse; respiratory rate; weight- before therapy starts and at each outpatient visit

  11. Nursing Process: Assessment • Ongoing assessment • Respiratory depression: • Take blood sample: For arterial blood gas analysis; determine effectiveness of analeptic • Observe: Adverse drug reaction; report occurrence immediately to PHCP

  12. Nursing Process: Nursing Diagnosis and Planning • Disturbed sleep pattern; ineffective breathing pattern; imbalanced nutrition • Expected outcomes: • Depends on reason for administration • Optimal response to therapy • Support patientneeds: Manage adverse drug reactions • Understanding: Drug regimen

  13. Nursing Process: Implementation • Promoting an optimal response to therapy: • Amphetamines: Used for short-term treatment of exogenous obesity • Long term use: Causes addiction and abuse

  14. Nursing Process: Implementation • Monitoring and managing patientneeds: • Disturbed sleep patterns: • CNS stimulant therapy: Causes insomnia; administer early in the day • Avoid: Coffee, tea, cola drinks, chocolate • Vital signs: Checked every 6 to 8 hours • Adverse reactions: Amphetamine use may require discontinuation of drug

  15. Nursing Process: Implementation • Monitoring and managing patient needs (cont’d): • Ineffective breathing pattern: • Use of analeptic drugs for respiratory stimulation: Enhances breathing pattern • Doxapram: Causes urinary retention; measure intake and output, notify PHCP if patientunable to void or bladder appears distended

  16. Geriatrics • *Older adults are more sensitive to CNS stimulants and may exhibit anxiety, nervousness, insomnia, mental confusion

  17. Nursing Process: Implementation • Monitoring and managing patient needs (cont’d): • Imbalanced nutrition: Less than bodily requirement • Adverse reactions: Use of CNS stimulants-child with ADHD decreases appetite • Long-term treatment: CNS stimulants-retards growth in children

  18. Nursing Process: Implementation • Monitoring and managing patientneeds (cont’d): • Imbalanced nutrition (cont’d): • Monitor: Weight, growth patterns in children on long-term treatment with CNS drugs • Frequently check: Height, weight of child to monitor growth • PHCP may periodically interrupt therapy to monitor effectiveness of therapy

  19. Nursing Process: Implementation • Educating the patientand family: • Therapeutic regimen, adverse drug reactions are explained to patientand family • Emphasize: Need to follow recommended dosage schedule • Develop a teaching plan

  20. Nursing Process: Implementation • Educating the patient and family (cont’d): • Additional teaching points: • Attention deficit hyperactivity disorder • Administer drug in morning 30 to 45 minutes before breakfast and before lunch. • Monitor and record behavior of child

  21. Nursing Process: Implementation • Educating the patient and family (cont’d): • Additional teaching points (cont’d): • Narcolepsy: • Record: Number of times per day periods of sleepiness occur • Amphetamines and anorexiants: • Avoid: coffee, tea, carbonated beverages containing caffeine

  22. Nursing Process: Evaluation • Child’s behavior, school performance-improves • Weight loss is achieved • Respiratory depression: Reversed • Fewer episodes of inappropriate sleep patterns reported • Adverse reactions are identified, reported, and managed

More Related